Daily Archives: July 6, 2022

Novel, Emerging Risk Factors for Colorectal Cancer Remain Understudied

For more than 3 decades, colorectal cancer (CRC) incidence rates have been increasing rapidly among adults Continue reading

Posted in News | Comments Off on Novel, Emerging Risk Factors for Colorectal Cancer Remain Understudied

Using Human Induced Pluripotent Stem Cell Derived Organoids to Identify New Pathologies in Patients with PDX1 Mutations

Two patients with homozygous mutations in PDX1 presented with pancreatic agenesis, chronic diarrhea and poor weight gain, the causes of which were not identified through routine clinical testing. We aim to perform a deep analysis of the stomach and int… Continue reading

Posted in News | Comments Off on Using Human Induced Pluripotent Stem Cell Derived Organoids to Identify New Pathologies in Patients with PDX1 Mutations

Treatment of IBS Using FMT: A Step Forward?

Posted in News | Comments Off on Treatment of IBS Using FMT: A Step Forward?

Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease: HLA-DQA1*05 Testing for Immunogenicity to anti-TNF Remains Relevant in IBD, But Depends on Therapeutic Drug Monitoring Strategy

Posted in News | Comments Off on Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease: HLA-DQA1*05 Testing for Immunogenicity to anti-TNF Remains Relevant in IBD, But Depends on Therapeutic Drug Monitoring Strategy